Oncopeptides AB (OND) - Financials, balance sheet (quarterly)

0.17520000 EUR

0.0018

1.02%

Last update Apr 24, 7:35 PM CEST

Market closed

Day range

0.17520000

0.17760000

Previous close

0.17700000

Open

0.17659999

Access this stock data via API

Oncopeptides AB

0.18

0.00

1.02%

Financials

Balance sheet

Fiscal date	Dec 2024	Sep 2024	Jun 2024	Mar 2024
Total assets	244.2M	319.2M	452.9M	199.7M
Current assets	217.1M	289.3M	420.6M	164.9M
Cash	178.5M	250.0M	383.3M	104.8M
Cash equivalents	—	—	—	0
Cash and cash equivalents	178.5M	250.0M	383.3M	104.8M
Other short term investments	—	—	—	—
Accounts receivable	34.2M	34.8M	32.5M	55.1M
Other receivables	—	—	—	—
Inventory	4.4M	4.5M	4.8M	5.0M
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	-1K	-1K
Non current assets	27.1M	29.9M	32.4M	34.8M
Properties	—	—	—	—
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	—	—	—	—
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	—	—	—
Investments and advances	—	—	—	—
Other non current assets	—	—	32.4M	34.8M
Total liabilities	189.9M	183.6M	260.0M	208.1M
Current liabilities	51.4M	46.3M	121.0M	68.7M
Accounts payable	18.2M	12.1M	8.8M	16.9M
Accrued expenses	—	—	—	—
Short term debt	—	—	—	—
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	—	—	—	—
Other current liabilities	33.2M	34.2M	112.2M	51.8M
Non current liabilities	138.6M	137.3M	139.0M	139.4M
Long term provisions	—	—	—	—
Long term debt	121.9M	117.2M	114.9M	113.6M
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	16.7M	20.1M	24.1M	25.8M
Shareholders equity
Common stock	—	—	—	—
Retained earnings	—	—	—	—
Other shareholders equity	—	—	—	—
Total shareholders equity	54.3M	135.7M	193.0M	-8.4M
Additional paid in capital	—	—	—	—
Treasury stock	—	—	—	—
Minority interest	—	—	—	—